BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Passweg JR, Baldomero H, Bregni M, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Kröger N, Farge-Bancel D, Gaspar HB, Marsh J, Mohty M, Peters C, Sureda A, Velardi A, Ruiz de Elvira C, Madrigal A; European Group for Blood and Marrow Transplantation. Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant 2013;48:1161-7. [PMID: 23584439 DOI: 10.1038/bmt.2013.51] [Cited by in Crossref: 84] [Cited by in F6Publishing: 85] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Sheshadri A, Sacks NC, Healey BE, Raza S, Boerner G, Huang HJ. Lung Function Monitoring After Lung Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation. Clin Ther 2022:S0149-2918(22)00115-1. [PMID: 35513911 DOI: 10.1016/j.clinthera.2022.03.011] [Reference Citation Analysis]
2 Zhou B, Xu M, Lu S, Liu Y, Qi L, Liu T, Tian H, Chen J, Wu D, Xu Y. The clinical outcomes of B-cell Acute Lymphoblastic Leukemia Patients Treated with Haploidentical Stem Cells Combined with Umbilical Cord Blood Transplantation. Transplant Cell Ther 2021:S2666-6367(21)01411-1. [PMID: 34954150 DOI: 10.1016/j.jtct.2021.12.010] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Livingston J, Di-Mola M, Lowry J, Ruse N, Chiang KY, Chopra Y, Schechter T, Ali M, Licht C, Wall D, Krueger J. Peripheral venous catheter collection of immune effector cells and hematopoietic stem cells is feasible and safe in older pediatric patients. Transfusion 2021;61:3413-9. [PMID: 34751944 DOI: 10.1111/trf.16717] [Reference Citation Analysis]
4 Atoui A, Omeirat N, Fakhreddine O, El Alam R, Kanafani Z, Abou Dalle I, Bazarbachi A, El-Cheikh J, Kanj SS. The Use of Voriconazole as Primary Prophylaxis for Invasive Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation: A Single Center's Experience. J Fungi (Basel) 2021;7:925. [PMID: 34829213 DOI: 10.3390/jof7110925] [Reference Citation Analysis]
5 Ahmed SO, El Fakih R, Elhaddad A, Ali Hamidieh A, Altbakhi A, Chaudhry QU, Bazarbachi A, Adil S, Al-Khabori M, Ben Othman T, Gaziev J, Khalaf M, Alshammeri S, Alotaibi S, Alshahrani M, Bekadja MA, Ibrahim A, Al-Wahadneh AM, Altarshi M, Alsaeed A, Madani A, Abboud M, Abujazar H, Bakr M, Abosoudah I, El Cheikh J, Almasari A, Alfraih F, Baldomero H, Elsolh H, Niederwieser D, Chaudhri N, Aljurf M. Strategic priorities for hematopoietic stem cell transplantation in the EMRO region. Hematol Oncol Stem Cell Ther 2021:S1658-3876(21)00090-X. [PMID: 34688625 DOI: 10.1016/j.hemonc.2021.09.006] [Reference Citation Analysis]
6 Wang J, Duan X, Yang L, Liu X, Hao C, Dong H, Gu H, Tang H, Dong B, Zhang T, Gao G, Liang R. Comparison of Survival Between Autologous and Allogeneic Stem Cell Transplantation in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Meta-Analysis.Cell Transplant. 2020;29:963689720975397. [PMID: 33238731 DOI: 10.1177/0963689720975397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ke P, Zhang X, Liu S, Zhu Q, Ma X, Chen F, Tang X, Han Y, Fu Z, Chen S, Wu D, Qiu H, Zhou J, Bao X. The time-dependent effects of early-onset Epstein-Barr viremia on adult acute leukemia patients following allo-HSCT with ATG-containing MAC regimen. Ann Hematol 2021;100:1879-89. [PMID: 33885923 DOI: 10.1007/s00277-021-04528-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Frascino AV, Fava M, Collassanti MDS, Odone-Filho V. Impact of Pediatric Hematopoietic Stem-Cell Transplantation on Craniofacial Growth. Clinics (Sao Paulo) 2020;75:e1901. [PMID: 33146356 DOI: 10.6061/clinics/2020/e1901] [Reference Citation Analysis]
9 Petukhova EO, Mukhamedshina YO, Salafutdinov II, Garanina EE, Kaligin MS, Leushina AV, Rizvanov AA, Reis HJ, Palotás A, Zefirov AL, Mukhamedyarov MA. Effects of Transplanted Umbilical Cord Blood Mononuclear Cells Overexpressing GDNF on Spatial Memory and Hippocampal Synaptic Proteins in a Mouse Model of Alzheimer's Disease. J Alzheimers Dis 2019;69:443-53. [PMID: 30958382 DOI: 10.3233/JAD-190150] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
10 Sheikh MA, Toledano M, Ahmed S, Gul Z, Hashmi SK. Noninfectious neurologic complications of hematopoietic cell transplantation: A systematic review. Hematol Oncol Stem Cell Ther 2021;14:87-94. [PMID: 32516577 DOI: 10.1016/j.hemonc.2020.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Sureda A, Genadieva Stavrik S, Boumendil A, Finel H, Khvedelidze I, Dietricht S, Dreger P, Hermine O, Kyriakou C, Robinson S, Schmitz N, Schouten HC, Tanase A, Montoto S. Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT. Bone Marrow Transplant 2020;55:2170-9. [PMID: 32415225 DOI: 10.1038/s41409-020-0929-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 van der Lans MCM, Witkamp FE, Oldenmenger WH, Broers AEC. Five Phases of Recovery and Rehabilitation After Allogeneic Stem Cell Transplantation: A Qualitative Study. Cancer Nurs 2019;42:50-7. [PMID: 28426538 DOI: 10.1097/NCC.0000000000000494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Sanz-piña E, Santurtún A, Zarrabeitia MT. Forensic implications of the presence of chimerism after hematopoietic stem cell transplantation. Forensic Science International 2019;302:109862. [DOI: 10.1016/j.forsciint.2019.06.020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Giebel S, Boumendil A, Labopin M, Seesaghur A, Baron F, Ciceri F, Esteve J, Gorin NC, Savani B, Schmid C, Wetten S, Mohty M, Nagler A. Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Ann Hematol 2019;98:2389-98. [PMID: 31392462 DOI: 10.1007/s00277-019-03771-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
15 Robin C, Cordonnier C, Sitbon K, Raus N, Lortholary O, Maury S, Peffault de la Tour R, Bretagne S, Bastuji-garin S. Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Biology of Blood and Marrow Transplantation 2019;25:354-61. [DOI: 10.1016/j.bbmt.2018.09.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
16 Itzykson R, Fenaux P, Bowen D, Cross NCP, Cortes J, De Witte T, Germing U, Onida F, Padron E, Platzbecker U, Santini V, Sanz GF, Solary E, Van de Loosdrecht A, Malcovati L. Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet. Hemasphere. 2018;2:e150. [PMID: 31723789 DOI: 10.1097/hs9.0000000000000150] [Cited by in Crossref: 36] [Cited by in F6Publishing: 50] [Article Influence: 9.0] [Reference Citation Analysis]
17 Muroi K. Trends in peripheral stem/progenitor cell manipulation and clinical application. Transfus Apher Sci 2018;57:600-5. [PMID: 30224153 DOI: 10.1016/j.transci.2018.09.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Rožman P. The potential of non-myeloablative heterochronous autologous hematopoietic stem cell transplantation for extending a healthy life span. Geroscience 2018;40:221-42. [PMID: 29948868 DOI: 10.1007/s11357-018-0027-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
19 Dessels C, Alessandrini M, Pepper MS. Factors Influencing the Umbilical Cord Blood Stem Cell Industry: An Evolving Treatment Landscape. Stem Cells Transl Med. 2018;7:643-650. [PMID: 29777574 DOI: 10.1002/sctm.17-0244] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
20 Besson N, Topholm Bruun M, Stauffer Larsen T, Nielsen C. Impact of apheresis automation on procedure quality and predictability of CD34 + cell yield. J Clin Apher 2018;33:494-504. [DOI: 10.1002/jca.21625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Debals-Gonthier M, Siani C, Faucher C, Touzani R, Lemarié-Basset C, Chabannon C, Furst S, Devillier R, Harbi S, Castagna L, Caymaris L, Blaise D, Le Corroller Soriano AG. Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years. Bone Marrow Transplant 2018;53:1096-104. [PMID: 29523885 DOI: 10.1038/s41409-018-0133-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
22 Suárez-González J, Martínez-Laperche C, Kwon M, Balsalobre P, Carbonell D, Chicano M, Rodríguez-Macías G, Serrano D, Gayoso J, Díez-Martín JL, Buño I. Donor Cell-Derived Hematologic Neoplasms after Hematopoietic Stem Cell Transplantation: A Systematic Review. Biol Blood Marrow Transplant 2018;24:1505-13. [PMID: 29410295 DOI: 10.1016/j.bbmt.2018.01.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
23 Mukhamedyarov MA, Leushina AV, Tikhonova AE, Petukhova EO, Garanina EE, Ben Taleb R, Kaligin MS, Mukhamedshina YO, Rizvanov AA, Zefirov AL, Islamov RR. Intravenous Transplantation of Human Umbilical Cord Blood Mononuclear Cells Overexpressing Nerve Growth Factor Improves Spatial Memory in APP/PS1 Transgenic Mice with a Model of Alzheimer’s Disease. BioNanoSci 2018;8:473-80. [DOI: 10.1007/s12668-017-0497-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Premstaller M, Perren M, Koçack K, Arranto C, Favre G, Lohri A, Gerull S, Passweg JR, Halter JP, Leuppi-Taegtmeyer AB. Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up data. J Clin Lipidol 2018;12:464-480.e3. [PMID: 29310991 DOI: 10.1016/j.jacl.2017.11.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
25 Ke P, Bao X, Hu X, Zhuang J, Wu X, Liu Y, He X, Wu D, Xue S, Ma X. Myeloablative conditioning regimens with combined of haploidentical and cord blood transplantation for myelodysplastic syndrome patients. Bone Marrow Transplant 2018;53:162-8. [DOI: 10.1038/bmt.2017.229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
26 Garbin LM, Simões BP, Curcioli ACJV, de Carvalho EC. Serum Cyclosporine Levels: The Influence of the Time Interval Between Interrupting the Infusion and Obtaining the Samples: A Randomized Clinical Trial. Cancer Nurs 2018;41:E55-61. [PMID: 29049039 DOI: 10.1097/NCC.0000000000000544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Pahnke S, Larfors G, Axdorph-Nygell U, Fischer-Nielsen A, Haastrup E, Heldal D, Itälä-Remes M, Johansson JE, Kauppila M, Lenhoff S, Ljungman P, Niittyvuopio R, Sandstedt A, Hägglund H. Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors. J Clin Apher 2018;33:226-35. [PMID: 28833474 DOI: 10.1002/jca.21576] [Reference Citation Analysis]
28 Krasna M, Malicev E, Rozman JZ, Vrtovec B. Assessment of stability of CD34+ cell products enriched by immunoselection from peripheral blood mononuclear cells during refrigerated storage. Transfus Apher Sci 2017;56:566-70. [PMID: 28800845 DOI: 10.1016/j.transci.2017.07.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
29 Kim-Wanner SZ, Bug G, Steinmann J, Ajib S, Sorg N, Poppe C, Bunos M, Wingenfeld E, Hümmer C, Luxembourg B, Seifried E, Bonig H. Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMC. J Transl Med 2017;15:174. [PMID: 28800741 DOI: 10.1186/s12967-017-1277-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
30 Liso A, Neri M, Maglietta F, La Russa R, Turillazzi E. Hematopoietic Stem Cell Transplantation: A Bioethical Lens. Stem Cells Int 2017;2017:1286246. [PMID: 28740510 DOI: 10.1155/2017/1286246] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
31 Colombo AA, Marchioni E, Diamanti L, Di Matteo AM, Baldanti F, Furione M, Cazzola M, Ferretti VV, Pascutto C, Alessandrino EP. Neurological Complications Involving the Central Nervous System After Allogeneic Hematopoietic Stem Cell Transplantation During a Period of Evolution in Transplant Modalities: A Cohort Analysis. Transplantation. 2017;101:616-623. [PMID: 27222935 DOI: 10.1097/tp.0000000000001257] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
32 Marks DI, Liu Q, Slavin M. Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation. Expert Rev Anti Infect Ther 2017;15:493-502. [PMID: 28335642 DOI: 10.1080/14787210.2017.1305886] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
33 Baumgartner A, Bargetzi M, Bargetzi A, Zueger N, Medinger M, Passweg J, Schanz U, Samaras P, Chalandon Y, Pichard C, Limonta A, Wannesson L, Pabst T, Duchosal MA, Hess U, Stanga Z, Mueller B, Schuetz P. Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison. Nutrition 2017;35:43-50. [DOI: 10.1016/j.nut.2016.10.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
34 de Witte T, Bowen D, Robin M, Malcovati L, Niederwieser D, Yakoub-Agha I, Mufti GJ, Fenaux P, Sanz G, Martino R, Alessandrino EP, Onida F, Symeonidis A, Passweg J, Kobbe G, Ganser A, Platzbecker U, Finke J, van Gelder M, van de Loosdrecht AA, Ljungman P, Stauder R, Volin L, Deeg HJ, Cutler C, Saber W, Champlin R, Giralt S, Anasetti C, Kröger N. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel. Blood 2017;129:1753-62. [PMID: 28096091 DOI: 10.1182/blood-2016-06-724500] [Cited by in Crossref: 158] [Cited by in F6Publishing: 168] [Article Influence: 31.6] [Reference Citation Analysis]
35 Fürst D, Niederwieser D, Bunjes D, Wagner EM, Gramatzki M, Wulf G, Müller CR, Neuchel C, Tsamadou C, Schrezenmeier H, Mytilineos J. Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantation. Haematologica 2017;102:796-803. [PMID: 28057735 DOI: 10.3324/haematol.2016.151340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
36 Bergkvist K, Larsen J, Johansson UB, Mattsson J, Fossum B. Family members' life situation and experiences of different caring organisations during allogeneic haematopoietic stem cells transplantation-A qualitative study. Eur J Cancer Care (Engl) 2018;27. [PMID: 27859940 DOI: 10.1111/ecc.12610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
37 Kuba K, Esser P, Scherwath A, Schirmer L, Schulz-Kindermann F, Dinkel A, Balck F, Koch U, Kröger N, Götze H, Mehnert A. Cancer-and-treatment-specific distress and its impact on posttraumatic stress in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Psychooncology 2017;26:1164-71. [PMID: 27718504 DOI: 10.1002/pon.4295] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
38 Espigado I, Ortega-Ortega M, Montero-Granados R, Rodriguez-Torres N, Márquez-Malaver FJ. Differences in stem cell transplantation activity among regions in Spain: an economic explanation. Bone Marrow Transplant 2016;51:1537-9. [PMID: 27376450 DOI: 10.1038/bmt.2016.177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
39 Douglas AP, Slavin MA. Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field. Expert Rev Anti Infect Ther 2016;14:1165-77. [PMID: 27710140 DOI: 10.1080/14787210.2016.1245613] [Reference Citation Analysis]
40 Greer M, Riise GC, Hansson L, Perch M, Hämmäinen P, Roux A, Hirschi S, Lhuillier E, Reynaud-gaubert M, Philit F, Claustre J, Stern M, Gottlieb J, Holm AM. Dichotomy in pulmonary graft- versus -host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation. Eur Respir J 2016;48:1807-10. [DOI: 10.1183/13993003.01121-2016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
41 Hesstvedt L, Arendrup MC, Poikonen E, Klingpor L, Friman V, Nordøy I; The Swedish fungal Surveillance Group Collaborators (16). Differences in epidemiology of candidaemia in the Nordic countries - what is to blame? Mycoses 2017;60:11-9. [DOI: 10.1111/myc.12535] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
42 Fonseca-Hial AM, Parisio K, Oliveira JS. Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders. Rev Bras Hematol Hemoter 2016;38:99-105. [PMID: 27208567 DOI: 10.1016/j.bjhh.2016.02.006] [Reference Citation Analysis]
43 Kuehl R, Schmidt ME, Dreger P, Steindorf K, Bohus M, Wiskemann J. Determinants of exercise adherence and contamination in a randomized controlled trial in cancer patients during and after allogeneic HCT. Support Care Cancer 2016;24:4327-37. [PMID: 27189616 DOI: 10.1007/s00520-016-3271-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
44 Kresnik PK, Krasna M, Rozman P, Vrtovec B, Malicev E. Collection and immunoselection of CD34+ cells: the impact of age, sex, and diabetes in patients with chronic heart failure. Transfusion 2016;56:1792-800. [PMID: 27185200 DOI: 10.1111/trf.13646] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
45 Lu D, Hart LK, Lutgendorf SK, Oh H, Silverman M. Effects of Healing Touch and Relaxation Therapy on Adult Patients Undergoing Hematopoietic Stem Cell Transplant: A Feasibility Pilot Study. Cancer Nursing 2016;39:E1-E11. [DOI: 10.1097/ncc.0000000000000272] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
46 Linjama T, Impola U, Niittyvuopio R, Kuittinen O, Kaare A, Rimpiläinen J, Volin L, Peräsaari J, Jaatinen T, Lauronen J, Saarinen T, Juvonen E, Partanen J, Koskela S. Conflicting HLA assignment by three different typing methods due to the apparent loss of heterozygosity in the MHC region: Conflicting HLA assignment in haematological patients. HLA 2016;87:350-5. [DOI: 10.1111/tan.12770] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
47 Yuan S, Palmer JM, Tsai N, Dagis A, Nademanee A, Wang S. Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor: Post-transplant outcomes in plerixafor-mobilized HL patients. Hematological Oncology 2017;35:281-7. [DOI: 10.1002/hon.2286] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
48 Smeland KB, Kiserud CE, Lauritzsen GF, Blystad AK, Fagerli UM, Falk RS, Fluge Ø, Fosså A, Kolstad A, Loge JH, Maisenhölder M, Østenstad B, Kvaløy S, Holte H. A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma. Br J Haematol 2016;173:432-43. [PMID: 26914167 DOI: 10.1111/bjh.13965] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
49 Bacigalupo A, Dominietto A, Ghiso A, Di Grazia C, Lamparelli T, Gualandi F, Bregante S, Van Lint MT, Geroldi S, Luchetti S, Grasso R, Pozzi S, Colombo N, Tedone E, Varaldo R, Raiola AM. Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update. Bone Marrow Transplant 2015;50 Suppl 2:S37-9. [PMID: 26039205 DOI: 10.1038/bmt.2015.93] [Cited by in Crossref: 109] [Cited by in F6Publishing: 105] [Article Influence: 18.2] [Reference Citation Analysis]
50 Anthias C, Billen A, Arkwright R, Szydlo RM, Madrigal JA, Shaw BE. Harvests from bone marrow donors who weigh less than their recipients are associated with a significantly increased probability of a suboptimal harvest yield: IMPACT OF DONOR WEIGHT ON BM HARVEST YIELD. Transfusion 2016;56:1052-7. [DOI: 10.1111/trf.13509] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
51 Noerskov KH, Schjødt I, Syrjala KL, Jarden M. Sexual function 1-year after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2016;51:833-40. [PMID: 26878660 DOI: 10.1038/bmt.2015.342] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
52 Aljurf M, Nassar A, Hamidieh AA, Elhaddad A, Hamladji R, Bazarbachi A, Ibrahim A, Ben Othman T, Abdel-rahman F, Alseraihy A, Fahmy O, Hussein AA, Alabdulaaly A, Adil S, Alkindi SSA, Bayoumy M, Dennison D, Bekadja MA, Redhouane AN, Rasheed W, Alsagheir A, Alsudairy R, Ladeb S, Benchekroun S, Ramzi M, Ahmed P, Elsolh H, Ahmed SO, Hussain F, Ghavamzadeh A. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011–2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT). Hematology/Oncology and Stem Cell Therapy 2015;8:167-75. [DOI: 10.1016/j.hemonc.2015.09.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
53 Anthias C, O'Donnell PV, Kiefer DM, Yared J, Norkin M, Anderlini P, Savani BN, Diaz MA, Bitan M, Halter JP, Logan BR, Switzer GE, Pulsipher MA, Confer DL, Shaw BE. European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards. Biol Blood Marrow Transplant 2016;22:514-9. [PMID: 26597079 DOI: 10.1016/j.bbmt.2015.11.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
54 Schuler M, Hornemann B, Pawandenat C, Kramer M, Hentschel L, Beck H, Kasten P, Singer S, Schaich M, Ehninger G, Platzbecker U, Schetelig J, Bornhäuser M. Feasibility of an exercise programme in elderly patients undergoing allogeneic stem cell transplantation - a pilot study. Eur J Cancer Care 2016;25:839-48. [DOI: 10.1111/ecc.12400] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
55 Worel N. ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation. Transfus Med Hemother 2016;43:3-12. [PMID: 27022317 DOI: 10.1159/000441507] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
56 Ciáurriz M, Zabalza A, Beloki L, Mansilla C, Pérez-Valderrama E, Lachén M, Bandrés E, Olavarría E, Ramírez N. The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients. Cell Mol Life Sci. 2015;72:4049-4062. [PMID: 26174234 DOI: 10.1007/s00018-015-1986-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
57 Du H, Chen J, Qin M, Fang J, Li Z, Zhu Y, Sun X, Huang D, Yu J, Tang Y, Hu S, Li J, Zhang Z, Luan Z. Pediatric hematopoietic stem cell transplantation in China: Data and trends during 1998-2012. Pediatr Transplant 2015;19:563-70. [PMID: 26058853 DOI: 10.1111/petr.12525] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
58 Ali N, Adil SN, Shaikh MU. Autologous Hematopoietic Stem Cell Transplantation-10 Years of Data From a Developing Country. Stem Cells Transl Med. 2015;4:873-877. [PMID: 26032748 DOI: 10.5966/sctm.2015-0015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
59 Moreau P, Attal M, Facon T. Frontline therapy of multiple myeloma. Blood 2015;125:3076-84. [DOI: 10.1182/blood-2014-09-568915] [Cited by in Crossref: 185] [Cited by in F6Publishing: 192] [Article Influence: 26.4] [Reference Citation Analysis]
60 Kerhuel L, Amorim S, Azoulay E, Thiéblemont C, Canet E. Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma. Leukemia & Lymphoma 2015;56:3090-5. [DOI: 10.3109/10428194.2015.1034700] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
61 Gratwohl A, Baldomero H, Passweg J. The role of hematopoietic stem cell transplantation in chronic myeloid leukemia. Ann Hematol. 2015;94 Suppl 2:S177-S186. [PMID: 25814084 DOI: 10.1007/s00277-015-2313-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
62 Lengliné E, Chevret S, Moreau AS, Pène F, Blot F, Bourhis JH, Buzyn A, Schlemmer B, Socié G, Azoulay E. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2015;50:840-5. [PMID: 25798675 DOI: 10.1038/bmt.2015.55] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 7.4] [Reference Citation Analysis]
63 Berger K, Schopohl D, Rieger C, Ostermann H. Economic and clinical aspects of intravenous versus oral busulfan in adult patients for conditioning prior to HSCT. Support Care Cancer 2015;23:3447-54. [PMID: 25773673 DOI: 10.1007/s00520-015-2695-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
64 Smagur A, Mitrus I, Ciomber A, Panczyniak K, Fidyk W, Sadus-wojciechowska M, Holowiecki J, Giebel S. Comparison of the cryoprotective solutions based on human albumin vs. autologous plasma: its effect on cell recovery, clonogenic potential of peripheral blood hematopoietic progenitor cells and engraftment after autologous transplantation. Vox Sang 2015;108:417-24. [DOI: 10.1111/vox.12238] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
65 Beije N, Versluis J, Kraan J, Gratama JW, Sleijfer S, Cornelissen JJ. Circulating endothelial cell enumeration demonstrates prolonged endothelial damage in recipients of myeloablative allogeneic stem cell transplantation. Haematologica 2015;100:e246-9. [PMID: 25710454 DOI: 10.3324/haematol.2014.121731] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
66 Sorg N, Poppe C, Bunos M, Wingenfeld E, Hümmer C, Krämer A, Stock B, Seifried E, Bonig H. Red blood cell depletion from bone marrow and peripheral blood buffy coat: a comparison of two new and three established technologies. Transfusion 2015;55:1275-82. [PMID: 25647556 DOI: 10.1111/trf.13001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
67 Moreau P, Attal M. All transplantation-eligible patients with myeloma should receive ASCT in first response. Hematology 2014;2014:250-4. [DOI: 10.1182/asheducation-2014.1.250] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
68 Estcourt LJ. Why has demand for platelet components increased? A review: Why has demand for platelet components increased? Transfusion Med 2014;24:260-8. [DOI: 10.1111/tme.12155] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
69 Chevallier P, Labopin M, Socie G, Rubio MT, Blaise D, Vigouroux S, Huynh A, Michallet M, Bay JO, Maury S, Yakoub-Agha I, Fegueux N, Deconinck E, Contentin N, Maillard N, Bulabois CE, Francois S, Oumedaly R, Raus N, Mohty M. Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC. Eur J Haematol 2015;94:449-55. [PMID: 25238651 DOI: 10.1111/ejh.12451] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
70 Sánchez-ortega I, Querol S, Encuentra M, Ortega S, Serra A, Sanchez-villegas JM, Grifols JR, Pujol-balaguer MM, Pujol-bosch M, Martí JM, Garcia-cerecedo T, Barba P, Sancho JM, Esquirol A, Sierra J, Duarte RF. Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization. Bone Marrow Transplant 2015;50:34-9. [DOI: 10.1038/bmt.2014.196] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
71 Bräuninger S, Thorausch K, Luxembourg B, Schulz M, Chow KU, Seifried E, Bonig H. Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation. Bone Marrow Transplant 2014;49:1419-25. [DOI: 10.1038/bmt.2014.171] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
72 Holbro A, Stern M, Infanti L, O'Meara A, Drexler B, Frey BM, Tiercy JM, Passweg JR, Gassner C, Buser A, Sigle JP. Impact of recipient ABH secretor status on outcome in minor ABO-incompatible hematopoietic stem cell transplantation. Transfusion 2015;55:64-9. [PMID: 24990435 DOI: 10.1111/trf.12768] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
73 Raiola AM, Dominietto A, di Grazia C, Lamparelli T, Gualandi F, Ibatici A, Bregante S, Van Lint MT, Varaldo R, Ghiso A, Gobbi M, Carella AM, Signori A, Galaverna F, Bacigalupo A. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts. Biol Blood Marrow Transplant 2014;20:1573-9. [PMID: 24910379 DOI: 10.1016/j.bbmt.2014.05.029] [Cited by in Crossref: 199] [Cited by in F6Publishing: 202] [Article Influence: 24.9] [Reference Citation Analysis]
74 D’rozario J, Parisotto R, Stapleton J, Gidley A, Owen D. Pre infusion, post thaw CD34+ peripheral blood stem cell enumeration as a predictor of haematopoietic engraftment in autologous haematopoietic cell transplantation. Transfusion and Apheresis Science 2014;50:443-50. [DOI: 10.1016/j.transci.2014.02.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
75 Hübel K, de la Rubia J, Azar N, Corradini P. Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective. Eur J Haematol 2015;94:12-22. [DOI: 10.1111/ejh.12362] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
76 Versluis J, Labopin M, Niederwieser D, Socie G, Schlenk RF, Milpied N, Nagler A, Blaise D, Rocha V, Cornelissen JJ, Mohty M. Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remission. Leukemia 2015;29:51-7. [PMID: 24913728 DOI: 10.1038/leu.2014.164] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
77 Manegold-brauer G, Borner B, Bucher C, Hoesli I, Passweg J, Girsberger S, Schoetzau A, Gisin S, Visca E. A prenatal prediction model for total nucleated cell count increases the efficacy of umbilical cord blood banking: Optimizing the Efficacy of UCB Banking. Transfusion 2014;54:2946-52. [DOI: 10.1111/trf.12676] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
78 Jantunen E, Varmavuo V. Plerixafor for mobilization of blood stem cells in autologous transplantation: an update. Expert Opin Biol Ther 2014;14:851-61. [PMID: 24673120 DOI: 10.1517/14712598.2014.902927] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
79 Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Farge-Bancel D, Gennery A, Halter J, Kröger N, Lanza F, Marsh J, Mohty M, Sureda A, Velardi A, Madrigal A; European Society for Blood and Marrow Transplantation EBMT. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant 2014;49:744-50. [PMID: 24637898 DOI: 10.1038/bmt.2014.55] [Cited by in Crossref: 110] [Cited by in F6Publishing: 101] [Article Influence: 13.8] [Reference Citation Analysis]
80 Martino M, Laszlo D, Lanza F. Long-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilization. Expert Opinion on Biological Therapy 2014;14:757-72. [DOI: 10.1517/14712598.2014.895809] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
81 Karafin MS, Graminske S, Erickson P, Walters MC, Scott EP, Carter S, Padmanabhan A. Evaluation of the spectra optia apheresis system for mononuclear cell (MNC) collection in G-CSF mobilized and nonmobilized healthy donors: Results of a multicenter study: Spectra Optia Mononuclear Cell Collection. J Clin Apheresis 2014;29:273-80. [DOI: 10.1002/jca.21319] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
82 Hefner J, Kapp M, Drebinger K, Dannenmann A, Einsele H, Grigoleit GU, Faller H, Csef H, Mielke S. High prevalence of distress in patients after allogeneic hematopoietic SCT: fear of progression is associated with a younger age. Bone Marrow Transplant. 2014;49:581-584. [PMID: 24442247 DOI: 10.1038/bmt.2013.228] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
83 Sohn SK, Moon JH. Adoptable strategic approaches to improve outcomes of allogeneic peripheral blood stem cell transplantations from unrelated donors. Transfusion 2014;54:1673-80. [PMID: 24261633 DOI: 10.1111/trf.12503] [Reference Citation Analysis]
84 Bürgler D, Medinger M, Passweg J, Fischmann A, Bucher C. Intra-arterial catheter guided steroid administration for the treatment of steroid-refractory intestinal GvHD. Leuk Res 2014;38:184-7. [PMID: 24268317 DOI: 10.1016/j.leukres.2013.10.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
85 Reddy NM, Oluwole O, Greer JP, Engelhardt BG, Jagasia MH, Savani BN. Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma. Exp Hematol 2014;42:39-45. [PMID: 24096123 DOI: 10.1016/j.exphem.2013.09.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]